Market closed
Inotiv/$NOTV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Inotiv
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Ticker
$NOTV
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
2,026
Website
Inotiv Metrics
BasicAdvanced
$155M
Market cap
-
P/E ratio
-$4.19
EPS
3.64
Beta
-
Dividend rate
Price and volume
Market cap
$155M
Beta
3.64
52-week high
$11.42
52-week low
$1.23
Average daily volume
939K
Financial strength
Current ratio
1.373
Quick ratio
0.798
Long term debt to equity
252.083
Total debt to equity
261.063
Interest coverage (TTM)
-1.84%
Management effectiveness
Return on assets (TTM)
-6.59%
Return on equity (TTM)
-49.61%
Valuation
Price to revenue (TTM)
0.314
Price to book
0.91
Price to tangible book (TTM)
-0.78
Price to free cash flow (TTM)
-5.292
Growth
Revenue change (TTM)
-14.27%
Earnings per share change (TTM)
2.18%
3-year revenue growth (CAGR)
76.27%
3-year earnings per share growth (CAGR)
180.43%
What the Analysts think about Inotiv
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Inotiv stock.
Inotiv Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Inotiv Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Inotiv News
AllArticlesVideos
Inotiv, Inc. (NOTV) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 weeks ago
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update
GlobeNewsWire·2 weeks ago
Inotiv Ranked Number 138 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Inotiv stock?
Inotiv (NOTV) has a market cap of $155M as of December 15, 2024.
What is the P/E ratio for Inotiv stock?
The price to earnings (P/E) ratio for Inotiv (NOTV) stock is 0 as of December 15, 2024.
Does Inotiv stock pay dividends?
No, Inotiv (NOTV) stock does not pay dividends to its shareholders as of December 15, 2024.
When is the next Inotiv dividend payment date?
Inotiv (NOTV) stock does not pay dividends to its shareholders.
What is the beta indicator for Inotiv?
Inotiv (NOTV) has a beta rating of 3.64. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.